Skip to main content
TBPH logo

TBPH

Theravance Biopharma Inc

$16.93

0.24%

Trade Ideas Performance

Latest Closed Trade Idea

$16.93

0.24%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

15

Social

18

About

Events of Theravance Biopharma Inc (TBPH)

Theravance Biopharma's stock has been impacted by several key events. The failure of the Ampreloxetine Phase 3 CYPRESS study led to a significant stock price drop. The company announced organizational restructuring to reduce costs and focus on YUPELRI, expecting substantial annualized cash flow. Earnings reports for Q3 2025, Q4 2025 and Q1 2026 showed growth in YUPELRI sales and revenue. A Strategic Review Committee is evaluating alternatives to maximize shareholder value.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Theravance Biopharma, Inc. (TBPH) Live Stock Price, Chart & Financial News | Edge Hound